The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CB8+ T cells

被引:102
作者
Punnonen, J [1 ]
Yssel, H [1 ]
de Vries, JE [1 ]
机构
[1] DNAX Res Inst Mol & Cellular Biol Inc, Dept Human Immunol, Palo Alto, CA 94304 USA
基金
芬兰科学院;
关键词
B lymphocytes; allergy; cytokines; isotype switching; T helper cells;
D O I
10.1016/S0091-6749(97)70276-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The relative contribution of IL-4 and IL-13 to the regulation of IgE synthesis has remained relatively poorly characterized, partially because of lack of suitable animal models. We have studied the roles of IL-4 and IL-13 in human IgE synthesis induced by supernatants derived from activated CD4(+) or CD8(+) T cell clones. Neutralizing anti-IL-4 and anti-IL-13 monoclonal antibodies (mAbs) inhibited IgE synthesis induced by anti-CD40 mAbs and supernatants from CD4(+) T cells by an average 61% and 42%, respectively (n = 25). Recombinant IL-13 had additive effects on IL-4-induced IgE synthesis, but only when IL-4 was present at low concentrations. Accordingly, IL-4 was the dominant IgE synthesis-inducing cytokine derived from highly polarized T helper (TH)(2) cells. However, anti-IL-13 mAbs also significantly inhibited IgE synthesis induced by two of three supernatants derived from allergen-specific T-H2-like cell lines generated from the skin of patients with atopic dermatitis. Furthermore, anti-IL-13 mAbs almost completely inhibited IgE synthesis induced by supernatants from T-H1 cells or CD8(+) T cell clones. Taken together, these data indicate that IL-13, in addition to IL-4, contributes to IgE synthesis induced by all T helper cell subsets, including allergen-specific T-H2 cells. Moreover, IL-13 appears to be the major IgE synthesis-inducing cytokine derived from T-H1 cells or CD8(+) T cells.
引用
收藏
页码:792 / 801
页数:10
相关论文
共 58 条
[1]   CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME [J].
ALLEN, RC ;
ARMITAGE, RJ ;
CONLEY, ME ;
ROSENBLATT, H ;
JENKINS, NA ;
COPELAND, NG ;
BEDELL, MA ;
EDELHOFF, S ;
DISTECHE, CM ;
SIMONEAUX, DK ;
FANSLOW, WC ;
BELMONT, J ;
SPRIGGS, MK .
SCIENCE, 1993, 259 (5097) :990-993
[2]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40 [J].
ARMITAGE, RJ ;
FANSLOW, WC ;
STROCKBINE, L ;
SATO, TA ;
CLIFFORD, KN ;
MACDUFF, BM ;
ANDERSON, DM ;
GIMPEL, SD ;
DAVISSMITH, T ;
MALISZEWSKI, CR ;
CLARK, EA ;
SMITH, CA ;
GRABSTEIN, KH ;
COSMAN, D ;
SPRIGGS, MK .
NATURE, 1992, 357 (6373) :80-82
[3]   THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
ARUFFO, A ;
FARRINGTON, M ;
HOLLENBAUGH, D ;
LI, X ;
MILATOVICH, A ;
NONOYAMA, S ;
BAJORATH, J ;
GROSMAIRE, LS ;
STENKAMP, R ;
NEUBAUER, M ;
ROBERTS, RL ;
NOELLE, RJ ;
LEDBETTER, JA ;
FRANCKE, U ;
OCHS, HD .
CELL, 1993, 72 (02) :291-300
[4]   THE 26-KD TRANSMEMBRANE FORM OF TUMOR-NECROSIS-FACTOR-ALPHA ON ACTIVATED CD4+ T-CELL CLONES PROVIDES A COSTIMULATORY SIGNAL FOR HUMAN B-CELL ACTIVATION [J].
AVERSA, G ;
PUNNONEN, J ;
DEVRIES, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) :1575-1585
[5]   AN INTERLEUKIN-4 (IL-4) MUTANT PROTEIN INHIBITS BOTH IL-4 OR IL-13-INDUCED HUMAN IMMUNOGLOBULIN-G4 (IGG4) AND IGE SYNTHESIS AND B-CELL PROLIFERATION - SUPPORT FOR A COMMON COMPONENT SHARED BY IL-4 AND IL-13 RECEPTORS [J].
AVERSA, G ;
PUNNONEN, J ;
COCKS, BG ;
MALEFYT, RD ;
VEGA, F ;
ZURAWSKI, SM ;
ZURAWSKI, G ;
DEVRIES, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2213-2218
[6]  
BRINKMANN V, 1995, J IMMUNOL, V154, P3078
[7]   Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain [J].
Caput, D ;
Laurent, P ;
Kaghad, M ;
Lelias, JM ;
Lefort, S ;
Vita, N ;
Ferrara, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16921-16926
[8]  
CHRETIEN I, 1989, J IMMUNOL METHODS, V117, P6781
[9]  
CLAASSEN JL, 1990, J IMMUNOL, V144, P2123
[10]  
CRONIN DC, 1995, J IMMUNOL, V154, P3118